Home › Therapeutic areas › Metabolic

Metabolic (30 companies · 36 conditions)

Conditions

Obesity 6 Type 1 Diabetes 6 Type 2 Diabetes 6 MASH 4 Adrenal Insufficiency 2 Classical Homocystinuria 2 Rare Congenital Adrenal Hyperplasia 2 Rare Gaucher Disease 2 Rare Glycogen Storage Disease Type Ia 2 Rare Gout 2 Phenylketonuria 2 Rare Pompe Disease 2 Rare Prader-Willi Syndrome 2 Rare Achondroplasia 1 Rare Acromegaly 1 Rare Aging-Related Frailty 1 Bardet-Biedl Syndrome 1 Rare Choline Deficiency 1 Congenital Hyperinsulinism 1 Rare Cushing's Syndrome 1 Rare Fabry Disease 1 Rare Hyperammonemia 1 Rare Long-Chain Fatty Acid Oxidation Disorders 1 Rare Menkes Disease 1 Rare Mucopolysaccharidosis Type IIIB 1 Rare Mucopolysaccharidosis Type VII 1 Rare Neonatal Diabetes Mellitus 1 Rare Osteogenesis Imperfecta 1 Rare Post-Bariatric Hypoglycemia 1 Rare Sanfilippo Syndrome 1 Rare Severe Primary IGF-1 Deficiency 1 Rare Tumor-Induced Osteomalacia 1 Rare Tyrosinemia Type 1 1 Rare Urea Cycle Disorders 1 Rare Wolfram Syndrome 1 Rare X-Linked Hypophosphatemia 1 Rare

Companies

Ticker	Company	Therapeutic areas	In Metabolic	Lead stage	Programs
ALT	Altimmune	GI/HepatologyMetabolic+1	1	Phase 2	3
AMLX	Amylyx Pharmaceuticals	MetabolicNeurology Rare	4	Phase 3	5
BEAM	Beam Therapeutics	HematologyMetabolic+1 Rare	2	Phase 1	7
BMEA	Biomea Fusion	Metabolic	4	Phase 2	5
IPSC	Century Therapeutics	ImmunologyMetabolic+1 Rare	1	Phase 1	11
CRNX	Crinetics Pharmaceuticals	MetabolicOncology Rare	4	Approved	6
DYN	Dyne Therapeutics	MetabolicNeurology Rare	1	NDA Submitted	10
ETON	Eton Pharmaceuticals	GI/HepatologyMetabolic+1 Rare	8	Approved	14
FBIO	Fortress Biotech	DermatologyHematology+1 Rare	3	Approved	12
GUTS	Fractyl Health	Metabolic	3	Phase 3	3
GANX	Gain Therapeutics	MetabolicNeurology Rare	1	Phase 2	5
KURA	Kura Oncology	MetabolicOncology	2	Approved	9
LGVN	Longeveron	CardiovascularMetabolic+1 Rare	1	Phase 2	4
GLUE	Monte Rosa Therapeutics	CardiovascularDermatology+2 Rare	1	Phase 1	8
NKTR	Nektar Therapeutics	DermatologyImmunology+2	1	Phase 2	11
TARA	Protara Therapeutics	DermatologyMetabolic+1 Rare	1	Phase 3	3
RLMD	Relmada Therapeutics	MetabolicOncology Rare	1	Phase 2	4
RYTM	Rhythm Pharmaceuticals	Metabolic Rare	13	Approved	13
SGMT	Sagimet Biosciences	DermatologyMetabolic	1	Phase 3	5
SANA	Sana Biotechnology	MetabolicOncology	2	Phase 1	5
SPRB	Spruce Biosciences	Metabolic Rare	2	Preclinical	2
GPCR	Structure Therapeutics	MetabolicRespiratory Rare	4	Phase 2	5
TVTX	Travere Therapeutics	MetabolicRenal Rare	1	Approved	7
TYRA	Tyra Biosciences	MetabolicOncology Rare	1	Phase 2	5
RARE	Ultragenyx Pharmaceutical	CardiovascularGI/Hepatology+2 Rare	8	Approved	12
QURE	uniQure	HematologyMetabolic+1 Rare	1	Approved	6
VKTX	Viking Therapeutics	GI/HepatologyMetabolic+1 Rare	4	Phase 3	9
VYGR	Voyager Therapeutics	MetabolicNeurology Rare	1	Phase 1	7
VTVT	vTv Therapeutics	MetabolicRespiratory Rare	4	Phase 3	8
WVE	Wave Life Sciences	MetabolicNeurology+1 Rare	2	Phase 2	5